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What is a Reasonable Compromise on Health Care Reform? 
 
By Peter Dreier - July 8, 2009, 7:55PM 
 
All politics is about the art of compromise. But when is a compromise a victory and when 
is it a sell out? 
A good compromise is one that improves people's lives, upholds basic principles, 
changes power relations, and lays the groundwork for further reform. 
There's lots of talk about "compromise" in the current debate over health care reform. But 
it isn't clear what standards pundits, politicians, lobbyists, and activists are using in 
determining what is and isn't a reasonable compromise.  
For progressives, the principles involved in health care reform are straightforward.  
First, it should be "universal" - everyone should be covered, regardless of income or 
medical condition. Now, more than 50 million Americans lack health insurance. A new 
report by the Robert Wood Johnson Foundation predicts that the number of uninsured 
could reach 66 million in ten years. 
Second, it should cover the medical services that Americans need. It should not exclude 
people with "pre-existing conditions" - people who need insurance the most. People 
should have easy access to doctors and nurses of their choice, with an emphasis on 
preventative and primary care. Doctors should be allowed to prescribe the medicines, 
conduct the tests, and perform the procedures that they and their patients think are 
appropriate. 
Third, it should be efficient in terms of costs. The U.S. now spends about twice per capita 
on health care (about $8,000), and a much higher proportion of our GDP (17%), than 
Canada and many European nations. Despite this, we still have many people who lack 
insurance, the highest infant mortality rate and the shortest life expectancy. For many 
Americans who have health insurance, the cost of premiums, and the cost for medicines 
and services not covered under their insurance plans, is untenable. Medical expenses is 
the biggest cause of bankruptcy. Administrative costs consume about three to six times 
that of Western European nations and Canada.  
Based on these principles, a single-payer health system would be the best reform. In this 
approach, doctors and other providers, hospitals, drug companies, and medical suppliers 
would remain private, as they are now. But the federal government would provide the 
insurance for everyone, replacing the current inefficient mosaic of private insurance 
corporations. One way to envision single-payer is "Medicare for All." 
Many health experts, as well as many Democrats in Congress, think that a single-payer 
system would be the most effective way to provide quality universal health insurance at a 
reasonable cost. But a single-payer system is "off the table," in terms of political reality, 
mostly because of the opposition of the insurance corporations and drug companies.  
So President Barack Obama and most Democrats in Congress are pushing for a "public 
option" -- a government insurance plan, like Medicare, for those who can't afford, or 
whose employers don't provide, decent private insurance. About 70% of Americans say 
they want a public option. Adopting such a plan should be a slam dunk. So why is it so 
controversial? Well, it really isn't, except inside the Beltway, where public opinion vies 
with campaign contributions for the hearts and minds of our elected officials.  
Why is a public option needed? Without it, it will be impossible to reduce the cost of 
health care, which is driven by the outrageous greed and costly inefficiencies of the 
insurance and drug industries. A public option would guarantee that every American 
would have access to health insurance and would provide a benchmark of costs and 
quality that could be used to compare to private insurance companies in order to hold 
them accountable. It also would reduce the per-capita cost of health care and save 
Americans money. 
As the New Republic recently noted in an editorial, under a public option, "The 
government can offer coverage cheaply, by taking advantage of its bargaining power and 
economies of scale. And, insofar as the goal of reform is to reduce the cost of care in the 
long run, by attacking the medical habits that encourage excessive or ineffective care, the 
government can make sure the public plan pays for services in ways that promote the 
most effective treatments." 
Although single-payer would be the best option, a public option is a reasonable 
compromise. Any bill without a public option is a sell out. It fails the test. It violates the 
principles that should undergird any health reform package. 
But, not surprisingly, the drug and insurance companies have been muddying the debate. 
They and their allies in Congress are now defining the public option as a "radical" idea. 
They are insisting on a "bipartisan" compromise that leaves out a public option. They're 
throwing up smokescreens like "socialized medicine" and "unfair competition." Their 
arguments are completely bogus, as well as hypocritical, but the media are letting them 
get away with it. 
As Jacob Hacker and Rahul Rajkumar explain in the New Republic: 
"Opponents of the plan paint a dystopian future in which the government takes over 
American medicine, limiting choice and competition. The claim is demonstrably false: If 
the public plan option were enacted, most Americans would continue to get private 
insurance through their employers as they do today, and the public plan would be just one 
choice offered alongside a menu of private plans. Yet a post-reform world of unraveling 
choices, runaway costs, and rampant health insecurity could well materialize--if critics 
get their way and the public plan dies as a health care bill wends its way to passage."  
So let's be clear. The insurance and drug companies are the biggest obstacles to real 
reform.  
The private insurance industry, led by its major lobby group, called America's Health 
Insurance Plans, reflects what is bad about our health care system. It is the insurance 
companies that come between doctors and their patients, telling them what they can and 
cannot do. It is the greed of the insurance industry that keeps people with "pre-existing 
conditions" from getting insurance and whose policies exclude so many services that 
people go bankrupt paying for out-of-pocket expenses. This is what's called rationing.  
It is the insurance industry that requires so much paperwork that its bloated 
administrative costs push up the cost of premiums, compared with the much lower 
administrative costs of Medicare, the government-run insurance program for seniors. A 
public option that competed with the private insurance companies would keep them on 
their toes, and force them to provide better policies at a more reasonable price, or face an 
exodus of consumers. That's why they don't want it. 
Likewise, the drug companies don't want a public option, which would expose how they 
inflate the cost of medicine that contributes to our expensive and inefficient health 
system. Drug prices in the US are much higher than in Canada and other countries that 
regulate costs.  
Recall that in 2003 the drug companies and their trade associations deployed nearly 700 
lobbyists to stamp out a proposal to permit the federal government to negotiate the cost of 
drugs for Medicare recipients. Instead, the Bush administration and the GOP-controlled 
Congress added a drug benefit to Medicare, but prohibited Medicare officials from 
negotiating prices with drug manufacturers. It also guaranteed that private insurance 
companies, not Medicare, administer the drug benefit program. This dramatically 
increased Medicare costs for taxpayers. Seniors, meanwhile, wound up paying much 
more in out-of-pocket expenses for prescription drugs.  
Faced with the possibility of a public option that will hold them accountable, the 
insurance companies, drug manufacturers, hospitals, and doctors lobby are pledging to 
voluntarily trim their costs. But if we've learned anything from the deregulation mania of 
the past few decades -- particularly how it unleashed an epidemic of irresponsible and 
predatory behavior by banks -- its that we can't expect for-profit corporations to police 
themselves. Even former Federal Reserve chair Alan Greenspan had to acknowledge that 
it doesn't work.  
To thwart any public option, the insurance and drug lobbies are flooding Congress with 
campaign contributions. The Washington Post recently reported that private insurance 
corporations, drug companies, hospitals, and their lobbyists spent more than $126 million 
on lobbying in the first quarter of this year - equal to about $1.4 million a day. According 
to the Post, the Pharmaceutical Research and Manufacturers of America (PhRMA) spent 
almost $7 million in the first quarter, double its lobbying warchest from last year. Its 
president is Billy Tauzin, a former Republican congressman from Louisiana. Pfizer, one 
of the biggest drug companies, spent $6 million on its own.  
These health industry lobby groups also hired more than 350 former government staff 
members and retired members of Congress to lobby for them. Two of them are former 
chiefs of staff for Sen. Max Baucus, chairman of the Senate Finance Committee, who is a 
key player in writing the health reform bill. More than 50 former employees of that 
committee or its members are now lobbying for the healthcare industry. Among the at 
least 10 former members of Congress peddling their influence are former House majority 
leaders Dick Armey (a Texas Republican) and Richard Gephardt (a Missouri Democrat), 
who are now paid lobbyists for a New Jersey pharmaceutical firm. 
Every Republican in the Senate is in the pockets of the insurance and drug lobbies, led by 
Charles Grassley of Iowa. Grassley, a key sponsor of that 2003 bill on behalf of the 
pharmaceutical lobby, is leading the opposition to a public option. The Republicans are 
united behind Grassley. They want a so-called "middle ground" that doesn't include a 
public option. But the public option is the middle ground - smack dab in-between a 
single-payer system and an unregulated "free market" run by the insurance and drug 
companies 
 
In the current issue of the National Journal, columnist Jonathan Rauch argues that it is 
worth scuttling the public option in order to win enough Republican votes to call health 
reform a bi-partisan compromise.  
He's wrong. Obama doesn't need any Republican votes to pass health care reform. It 
would be nice to have some. But it isn't worth bribing a few GOP Senators to support 
health care reform if it is stripped of its most important components and violates the 
principles of a reasonable compromise.  
A bigger problem is the handful of so-called "moderate" Democrats in Congress who say 
they oppose a public option or are sitting on the fence. They may not be owned by the 
drug and insurance companies, but it looks like they are for rent. They are led by Baucus, 
and include Senators Dianne Feinstein (Calif.), Kent Conrad (N.D.), Blanche Lincoln 
(Arkansas), Mary Landrieu (La.) and Kay Hagan (N.C.). Without these moderates, 
Obama can't get the 60 votes he needs to pass a filibuster-proof bill. 
What's needed now is a concerted grassroots campaign to target the moderate Democrats 
to support a public option. In recent weeks, groups such as Health Care for America Now 
(HCAN), the Service Employees International Union, and MoveOn.org have been 
focusing on these fence-sitters by running ads and mobilizing voters.  
But that's not enough to beat the influence of the insurance and drug companies. As 
Harold Meyerson wrote in a recent Washington Post column, it is time for President 
Obama to unleash his " greatest political asset, the list of 13 million supporters that the 
Obama presidential campaign amassed last year." That list includes large numbers of 
volunteers in every state and Congressional district. Utilizing that list to help promote 
Obama's agenda was the mission of Organizing for America, the group created after he 
won the White House. 
As a former community organizer, Obama knows that enacting any progressive 
legislation requires a combination of inside lobbying and outside protest, what activists 
call "street heat." That's the lesson of the progressive victories of the New Deal, the civil 
rights movement, the women's movement, and the environmental movement. 
The battle for health care reform is one of those rare historic crusades that comes along 
once in a generation, testing our capacity as a society to achieve major reform in a classic 
contest of organized people vs. organized money.  
If progressives and liberals had their druthers, a single-payer system would be part of the 
solution. It isn't - at least for the foreseeable future. But the fight for a public option - as 
part of a guarantee of affordable quality health insurance for every American -- is still a 
supremely worthy goal. It is a compromise that will make America a much more humane 
country and a long-overdue victory in a struggle that began in the New Deal. It will also 
guarantee that Obama will be viewed by historians as a courageous and transformational 
president.  
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